PE/Cyanine7 anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6pt7_PEslashCy7
C57BL/6 splenocytes were stained with CD8 (clone 53-6.7) PE/Cyanine7 and CD3 FITC.
  • 53-6pt7_PEslashCy7
    C57BL/6 splenocytes were stained with CD8 (clone 53-6.7) PE/Cyanine7 and CD3 FITC.
See PE/Cyanine7 spectral data
Cat # Size Price Quantity Avail. Save
100721 25 µg 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100722 100 µg 144€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, and immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
Product Citations
  1. Ding Z, et al. 2017. Sci Rep. 10.1038/s41598-017-12488-z. PubMed
  2. Tello‐Lafoz M, et al. 2017. Sci Rep. . 10.1038/s41598-017-16370-w. PubMed
  3. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  4. Jarick KJ, et al. 2018. Front Immunol. 9:1468. PubMed
  5. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  6. Dar HY, et al. 2018. Sci Rep. 8:2503. PubMed
  7. Dar HY, et al. 2018. Bone Rep. 8:46. PubMed
  8. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  9. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  10. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  11. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  12. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  13. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  14. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  15. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  16. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  17. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  18. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  19. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  20. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  21. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  22. Emily A Thompson et al. 2019. Cell reports. 26(11):2859-2867 . PubMed
  23. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  24. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  25. Lee YS, et al. 2019. Sci Adv. 5:eaaw4176. PubMed
  26. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  27. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  28. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  29. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  30. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  31. Wu FTH, et al. 2019. Br J Cancer. 120:196. PubMed
  32. Silva DA, et al. 2019. Nature. 565:186. PubMed
  33. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  34. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  35. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  36. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  37. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  38. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  39. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  40. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  41. Pietronigro E, et al. 2019. Sci Rep. 9:12055. PubMed
  42. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  43. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  44. Li J, et al. 2018. Immunity. 49:178. PubMed
  45. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  46. Domingo–Gonzalez R, et al. 2020. eLife. 9:e56890.. PubMed
  47. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  48. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  49. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  50. Muri J, et al. 2020. eLife. 9:e53627.. PubMed
  51. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  52. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  53. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  54. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  55. Neubert K, et al. 2014. J Immunol. 192:5830. PubMed
  56. Sakthivel P, et al. 2014. PLoS One. 9:100970. PubMed
  57. Wei M, et al. 2014. Protein Eng Des Sel. 27:289. PubMed
  58. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  59. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  60. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  61. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  62. Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
  63. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  64. Yabas M, et al. 2016. PLoS One. 11: 0146774. PubMed
  65. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  66. Ariyoshi Y, et al. 2016. Gene Ther. 10.1038/gt.2016.7. PubMed
  67. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  68. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  69. X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed
  70. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  71. Collinson-Pautz M, et al. 2016. PLoS One. 11:e0164547. PubMed
  72. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  73. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
RRID
AB_312760 (BioLegend Cat. No. 100721)
AB_312761 (BioLegend Cat. No. 100722)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 01.21.2014

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account